drugset / Trial / NCT04147013

Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS

NCT04147013

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a proposed randomized prospective study to evaluate both the anti-inflammatory and analgesic effects of a COX-2 inhibitor, celecoxib, in patients with aspirin-exacerbated respiratory disease and Chronic rhinosinusitis following endoscopic sinus surgery. The investigators hypothesize that supplementation with celecoxib can potentially improve surgical outcomes and reduce the postoperative usage of opioid analgesics without an increased risk of bleeding or asthma exacerbation

Timeline

Start
2020-02-18
Primary completion
2026-02
Completion
2026-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral